Cargando…

Lipomatrix: A Novel Ascorbyl Palmitate-Based Lipid Matrix to Enhancing Enteric Absorption of Serenoa Repens Oil

The class of lipophilic compounds coming from vegetal source represents a perspective in the adjuvant treatment of several human diseases, despite their poor bioavailability in humans. These compounds are generally soluble in fats and poorly soluble in water. The major reason for the poor bioavailab...

Descripción completa

Detalles Bibliográficos
Autores principales:	Fratter, Andrea, Mason, Vera, Pellizzato, Marzia, Valier, Stefano, Cicero, Arrigo Francesco Giuseppe, Tedesco, Erik, Meneghetti, Elisa, Benetti, Federico
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2019
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6386960/ https://www.ncbi.nlm.nih.gov/pubmed/30720739 http://dx.doi.org/10.3390/ijms20030669

Ejemplares similares

Sublingual Delivery of Astaxanthin through a Novel Ascorbyl Palmitate-Based Nanoemulsion: Preliminary Data
por: Fratter, Andrea, et al.
Publicado: (2019)

Is Serenoa repens Effective in the Treatment of Benign Prostatic Hyperplasia?
por: Çeker, Gökhan
Publicado: (2020)

Serenoa Repens: Does It have Any Role in the Management of Androgenetic Alopecia?
por: Murugusundram, Sundaram
Publicado: (2009)

A substitute variety for agronomically and medicinally important Serenoa repens (saw palmetto)
por: Jaiswal, Yogini, et al.
Publicado: (2019)

Comparison of the Phytochemical Composition of Serenoa repens Extracts by a Multiplexed Metabolomic Approach
por: Marti, Guillaume, et al.
Publicado: (2019)

Ascorbyl Palmitate Hydrogel for Local, Intestinal Delivery of Macromolecules
por: Zhai, Jinyi, et al.
Publicado: (2018)

Synthesis with Immobilized Lipases and Downstream Processing of Ascorbyl Palmitate
por: Tufiño, Carolina, et al.
Publicado: (2019)

Hexanic Extract of Serenoa repens (Permixon(®)): A Review in Symptomatic Benign Prostatic Hyperplasia
por: Blair, Hannah A.
Publicado: (2022)

Cytotoxicity and Genotoxicity Assessment of Ascorbyl Palmitate (AP) Food Additive
por: Sohrabi, Yousef, et al.
Publicado: (2018)

Enzymatic Synthesis of Ascorbyl Palmitate in a Rotating Bed Reactor
por: Holtheuer, Jessica, et al.
Publicado: (2023)

Inhibitors of apoptosis proteins in experimental benign prostatic hyperplasia: effects of serenoa repens, selenium and lycopene
por: Minutoli, Letteria, et al.
Publicado: (2014)

Correction to: Hexanic Extract of Serenoa repens (Permixon(®)): A Review in Symptomatic Benign Prostatic Hyperplasia
por: Blair, Hannah A.
Publicado: (2022)

The Role of Combination Therapy with α-Blockers and Hexanic Extract of Serenoa repens in the Treatment of LUTS/BPH
por: De Nunzio, Cosimo, et al.
Publicado: (2022)

Synthesis and In Vitro Characterization of Ascorbyl Palmitate-Loaded Solid Lipid Nanoparticles
por: Ledinski, Maja, et al.
Publicado: (2022)

Comparison of Serenoa repens With Tamsulosin in the Treatment of Benign Prostatic Hyperplasia: A Systematic Review and Meta-Analysis
por: Cai, Tong, et al.
Publicado: (2020)

Efficacy and tolerability of the hexanic extract of Serenoa repens compared to tamsulosin in moderate-severe LUTS-BPH patients
por: Alcaraz, Antonio, et al.
Publicado: (2021)

Modern extraction techniques and their impact on the pharmacological profile of Serenoa repens extracts for the treatment of lower urinary tract symptoms
por: De Monte, Celeste, et al.
Publicado: (2014)

Serenoa repens and Urtica dioica Fixed Combination: In-Vitro Validation of a Therapy for Benign Prostatic Hyperplasia (BPH)
por: Saponaro, Miriam, et al.
Publicado: (2020)

The Possible Role of Probiotic Supplementation in Inflammation: A Narrative Review
por: Colletti, Alessandro, et al.
Publicado: (2023)

Lipidosterolic Extract of Serenoa Repens Modulates the Expression of Inflammation Related-Genes in Benign Prostatic Hyperplasia Epithelial and Stromal Cells
por: Sirab, Nanor, et al.
Publicado: (2013)

Effect of Serenoa repens (Permixon®) on the expression of inflammation-related genes: analysis in primary cell cultures of human prostate carcinoma
por: Silvestri, Ida, et al.
Publicado: (2013)

Usefulness of Urea as a Means of Improving the Solubility of Poorly Water-Soluble Ascorbyl Palmitate
por: Inoue, Yutaka, et al.
Publicado: (2017)

Preparation of magnetic nanoparticle integrated nanostructured lipid carriers for controlled delivery of ascorbyl palmitate
por: Kalaycioglu, Gokce Dicle
Publicado: (2020)

Ascorbyl palmitate-incorporated paclitaxel-loaded composite nanoparticles for synergistic anti-tumoral therapy
por: Zhou, Min, et al.
Publicado: (2017)

Clinically Meaningful Improvements in LUTS/BPH Severity in Men Treated with Silodosin Plus Hexanic Extract of Serenoa Repens or Silodosin Alone
por: Boeri, Luca, et al.
Publicado: (2017)

Serenoa repens for the treatment of lower urinary tract symptoms due to benign prostatic enlargement: A systematic review and meta-analysis
por: Trivisonno, Leonel Fabrizio, et al.
Publicado: (2021)

Nutraceutical Approaches to Dyslipidaemia: The Main Formulative Issues Preventing Efficacy
por: Colletti, Alessandro, et al.
Publicado: (2022)

Survivin and NAIP in Human Benign Prostatic Hyperplasia: Protective Role of the Association of Serenoa repens, Lycopene and Selenium from the Randomized Clinical Study
por: Morgia, Giuseppe, et al.
Publicado: (2017)

The Clinical Impact of Hexanic Extract of Serenoa repens in Men with Prostatic Inflammation: A Post Hoc Analysis of a Randomized Biopsy Study
por: Samarinas, Michael, et al.
Publicado: (2020)

Spectroscopic, thermodynamic and molecular docking studies of bovine serum albumin interaction with ascorbyl palmitate food additive
por: Sohrabi, Yousef, et al.
Publicado: (2017)

A New Treatment for Local Adiposity with Ascorbic Acid and Ascorbyl-Palmitate Solution: Clinical and Histological Study
por: Scarano, Antonio, et al.
Publicado: (2020)

The Inhibitory Effects of Hydroxytyrosol, α-Tocopherol and Ascorbyl Palmitate on Lipid Peroxidation in Deep-Fat Fried Seafood
por: Theah, Audrey Yue Vern, et al.
Publicado: (2023)

Observational study: daily treatment with a new compound “tradamixina” plus serenoa repens for two months improved the lower urinary tract symptoms
por: Iacono, Fabrizio, et al.
Publicado: (2012)

Mechanism Study on Nanoparticle Negative Surface Charge Modification by Ascorbyl Palmitate and Its Improvement of Tumor Targeting Ability
por: Li, Lin, et al.
Publicado: (2022)

Effects of hexanic extract of serenoa repens (permixon(®) 160 mg) on inflammation biomarkers in the treatment of lower urinary tract symptoms related to benign prostatic hyperplasia
por: Latil, Alain, et al.
Publicado: (2015)

Clinical Benefit of Tamsulosin and the Hexanic Extract of Serenoa Repens, in Combination or as Monotherapy, in Patients with Moderate/Severe LUTS-BPH: A Subset Analysis of the QUALIPROST Study
por: Alcaraz, Antonio, et al.
Publicado: (2020)

Ascorbyl palmitate synthesis in an organic solvent system using a Celite-immobilized commercial lipase (Lipolase 100L)
por: Sharma, Shivika, et al.
Publicado: (2016)

Retraction Note: Observational study: daily treatment with a new compound “tradamixina” plus serenoa repens for two months improved the lower urinary tract symptoms
por: Iacono, Fabrizio, et al.
Publicado: (2016)

Hypothesis on Serenoa repens (Bartram) small extract inhibition of prostatic 5α-reductase through an in silico approach on 5β-reductase x-ray structure
por: Governa, Paolo, et al.
Publicado: (2016)

Efficacy and Safety of the Hexanic Extract of Serenoa repens vs. Watchful Waiting in Men with Moderate to Severe LUTS-BPH: Results of a Paired Matched Clinical Study
por: Alcaraz, Antonio, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_juh8qp5jk3uk3sii40s3u0kntr